Bioscience
BioCrossroads has stoked state's life sciences industry, but challenges remain
February 11, 2012
J.K. WallIn the 10 years BioCrossroads has been promoting life sciences in Indiana, the effort has netted more than 330 new companies,
an infusion of more than $330 million in venture capital, a tripling of exports, and a growing number of mentions in national
reports on life sciences.
MoreDow Agro posts record fourth quarter profit
February 2, 2012
IBJ Staff and Associated PressThe Indianapolis-based unit of Dow Chemical Co. saw earnings grow to $142 million, a fourth-quarter record and double the
$72 million reported for the 2010 period.
MoreBioCrossroads seeds upstart medical device maker
October 20, 2011
Chris O'MalleyBioCrossroads’ Indiana Seed Fund has invested $300,000 in a startup company chaired by a former Eli Lilly and Co. executive
developing an absorbable stent.
MoreEx-Dow Agro scientist makes plea in trade-secret case
September 15, 2011
Associated PressA former Indiana scientist has agreed to plead guilty to charges of illegally sending trade secrets worth $300 million to
China and Germany.
MoreMedical implant maker plans move from northern Indiana
August 4, 2011
Associated PressRochester Medical Implants plans to move operations from Rochester to Noblesville in October. The company has 28 employees.
MoreMore life sciences firms opt to launch products in Europe
July 30, 2011
Maria LaMagnaThe U.S. Food and Drug Administration's growing reputation for unpredictability is spurring some Indianapolis companies to
join counterparts elsewhere and introduce products in Europe. The upshot is that some Americans may never benefit from innovations
occurring in their backyards.
MoreIndiana life sciences leaders look toward the future
July 30, 2011
Chris O'MalleyFormer Eli Lilly and Co. vice president Richard Dimarchi, BioCrossroads President David Johnson, angel investor Oscar Moralez
and Purdue University Senior Vice President Alan Rebar discuss issues ranging from the depth of the life sciences industry
in Indiana to venture capital and Purdue's Discovery Park.
MoreTech district could boost Indianapolis' convention business
July 23, 2011
Scott OlsonThe Indianapolis Convention & Visitors Association plans to attract more life sciences conferences.
MoreLilly plans more investment in two-in-one drugs
June 28, 2011
J.K. WallIndianapolis-based drugmaker Eli Lilly on Tuesday will announce a multimillion-dollar investment to develop drugs that act
like two medicines in one. Lilly plans to add more scientists to back the effort.
MoreAnson Group CEO thrives on helping clients work with FDA
June 11, 2011
Ann FinchColleen Hittle became CEO and sole owner of the Indianapolis-based pharmaceutical and medical device consulting firm in April.
MoreCity to roll out plan for 16th Street tech corridor
June 10, 2011
Francesca JaroszThe city of Indianapolis plans to announce a major initiative to turn a stretch of 16th Street northwest of downtown into
a hub for biotechnology and other high-tech companies.
MoreLife sciences logistics firm opens new tissue storage facility
May 27, 2011
J.K. WallBioStorage Technologies' $4.6 million facility, located near the Indianapolis International Airport, will be used to prepare,
store and transport tissue and blood samples.
MoreTax breaks approved for bioanalytical lab operator
April 7, 2011
The Metropolitan Development Commission on Wednesday preliminarily approved Advion BioServices Inc.'s request for a tax abatement
to build a laboratory at Purdue Research Park in Indianapolis.
MoreBioanalytical researcher seeking abatement for new lab
April 5, 2011
Scott OlsonAdvion, a provider of bioanalytical research and a subsidiary of Ithaca, N.Y.-based Advion BioSciences Inc., is expected to
open the 22,000-square-foot lab in mid-May with 49 employees, according to the company's application.
MoreScientists question claims in biotech letter
April 1, 2011
Associated PressThe widespread Internet posting of a letter by a retired Purdue University researcher who says he has linked genetically modified
corn and soybeans to crop diseases and to abortions and infertility in livestock has raised concern among scientists that
the public will believe his unsupported claim is true.
MoreMarcadia Biotech principals ponder next course
March 22, 2011
Chris O'MalleyMarcadia execs French, Hawryluk reflect on massive growth of Carmel firm after sale to Roche.
MoreResearch jobs could flow from Purdue quad
March 19, 2011
Marc D. AllanPurdue University officials and others connected with the life sciences in Indiana say the planned $164 million Life and Health
Sciences Quadrangle at the West Lafayette campus will mean high-paying jobs, retention of highly skilled scientists, and researchers
who might well have left the state for either coast.
MoreMolecules are moneymakers for software firm Indigo BioSystems
January 29, 2011
Chris O'MalleyEli Lilly and Co. spin-off has landed new private investment and may double its work force this year.
MoreAprimo sale may usher in 'new wave' of tech deals
January 8, 2011
Chris O'MalleyObservers say conditions are ripening for more deals like the recent $525 million sale of Aprimo Inc. in the months ahead—not
only among IT firms, but also among biotech companies here.
MoreRoche acquires Marcadia Biotech
December 30, 2010
Chris O'MalleyMarcadia Biotech Inc., a Carmel-based biopharmaceutical company founded by prominent scientists from Eli Lilly and Co. in
2006, has been acquired by Swiss life sciences giant Roche.
MoreDow AgroSciences moves into new research facility
November 20, 2010
IBJ StaffThe division of Dow Chemical has a 15-year lease with Indianapolis-based developer Browning Investments on the two-story building
near West 96th Street.
MoreDow Agro acquires Colorado seed company
September 2, 2010
IBJ StaffGrand Valley Hybrids has been growing and conditioning hybrid seed corn in the West since 1946.
MoreLocal economic espionage case full of intrigue
September 1, 2010
Cory SchoutenThe government's allegations read like a spy novel: Dr. Ke-xue "John" Huang lands a job at Indianapolis-based
Dow AgroSciences and over five years works himself into a position of trust, with access to trade secrets and processes the
company has invested $300 million to develop.
MoreEx-Dow Agro scientist's espionage indictment unsealed
August 31, 2010
IBJ StaffA federal indictment unsealed Tuesday in Indianapolis charged 45-year-old Ke-xue "John" Huang
with theft and attempted
theft of trade secrets to benefit a foreign government.
MoreEx-Dow AgroSciences employee accused of stealing trade secrets
July 31, 2010
Chris O'MalleyThe U.S. Department of Justice has charged Ke-xue Huang, a native of China's Hunan province, of stealing trade secrets of
a Dow AgroSciences insecticide and giving them to the People's Republic of China. Federal agents arrested the former Dow Agro
scientist July 13 in Westboro, Mass.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
IBJ Featured Advertisers
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
graham. they are even better w/ roasted marshmallows and melted chocolate
Apparently ticket sales are slow too...mas emails have been sent by the speedway in a last ditch attempt to get place fans to come.
Garden Valley Veggie flavor Wheat Thins Toasted Chips. Don't judge until you try them, haters!
Doc, a few important errors in your statements:
(1) The developer is spending the CITY'S money (the city is paying for the cost of the garage), so the city can damn well insist on a quality design.
(2) The LAW requires the proposed building to comply with design standards, and insisting that people follow the law is not giving anyone the "run-around."
(3) A two-week delay to make some minimal aesthetic improvements is hardly a great imposition being imposed on the developer.
(4) If the developer would rather build a crappy building elsewhere with their own money, then they are welcome to pick up and do so.
(4) Indianapolis is a major city, not some podunk town that needs to spread its legs for any developer that throws the place a sideways glance. Indianapolis should insist on the best, not settle for junk. Accepting anything is not going to make Indianapolis grow any faster (not sure where you got that silly notion from), nor is Indianapolis a slow-growth city compared to similarly sized city's in the Midwest.
Alone. Or with cheese.